Raleigh, NC, United States of America

Kathryn L Reed


Average Co-Inventor Count = 5.2

ph-index = 7

Forward Citations = 127(Granted Patents)


Company Filing History:


Years Active: 1996-2007

Loading Chart...
24 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Kathryn L Reed in Retroviral Research

Introduction

Kathryn L Reed is a renowned inventor based in Raleigh, NC, with an impressive portfolio of 24 patents to her name. Her innovative contributions have significantly impacted the field of pharmaceuticals, particularly in the development of retroviral protease inhibitors aimed at combating HIV.

Latest Patents

Among her latest patents, Kathryn has developed novel compounds that demonstrate efficacy as retroviral protease inhibitors. One such patent addresses N-heterocyclic moiety containing hydroxyethylamine compounds, which are particularly effective in inhibiting HIV protease. Another notable patent focuses on cyclic sulfone moiety-containing hydroxyethylamine protease inhibitor compounds, specifically designed to serve as inhibitors for HIV protease as well. These inventions showcase her commitment to advancing therapeutic options for those affected by retroviral infections.

Career Highlights

Kathryn L Reed has built a successful career working with prestigious companies such as Monsanto Company and G.D. Searle & Company. Her experience in these organizations allowed her to focus on innovative research and the development of groundbreaking pharmaceutical solutions.

Collaborations

Throughout her career, Kathryn has collaborated with notable professionals in her field such as Daniel P Getman and Robert M Heintz. These collaborations have fostered the exchange of knowledge and expertise, contributing to the successful development of her patented inventions.

Conclusion

Kathryn L Reed's contributions to the field of retroviral research underscore her role as a leading inventor and innovator. With her significant patent portfolio and collaborations with esteemed colleagues, she continues to influence the pharmaceutical landscape in the fight against HIV, solidifying her legacy in the world of medical research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…